JP TSE 4516 Pharmaceutical

Nippon Shinyaku Co.,Ltd.

日本新薬株式会社

Revenue

¥171B

≈ $1.1B

Net income

¥29.7B

≈ $188.3M

Income taxes paid

¥10.2B

≈ $64.9M

Total assets

¥346B

≈ $2.2B

Equity ratio

84.2%

Ranked #376 among listed Japanese companies by corporate taxes paid · effective tax rate 18.5%.

Share price at fiscal year-end: ¥5,116 · market capitalization ¥359B · P/E 11.6 · P/B 1.23

US dollar amounts use ¥157.8 per dollar.

Annual results

Fiscal year	Revenue	Net income	Tax expense	Taxes paid	Total assets	Net assets	Equity ratio	Source
Mar 2026	¥171B	¥29.7B	¥6.7B	¥10.2B	¥346B	¥292B	84.2%	EDINET (consol.)
Mar 2025	¥160B	¥32.6B	¥3.6B	¥8.1B	¥284B	¥247B	87.1%	EDINET (consol.)
Mar 2024	¥148B	¥25.9B	—	—	¥263B	¥220B	83.6%	EDINET (consol.)
Mar 2023	¥144B	¥22.8B	—	—	¥237B	¥196B	82.4%	EDINET (consol.)
Mar 2022	¥138B	¥23.0B	—	—	¥210B	¥177B	84.2%	EDINET (consol.)

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.